CYP19A1 and breast carcinoma: The development of postmenopausal estrogen receptor (ER)+ breast cancer is driven by local synthesis of estrogen, while calcitriol acts as a suppressor of aromatase expression (important in the synthesis of estrogen) [8] and downregulator of ER receptors [1,9].